Liraglutide generally begins to work within appetite effect within the first week, with the effect lasting 24 hours, daily dosing. The exact timing depends on dose, food, formulation and individual metabolism.
Key takeaways
- Typical onset: appetite effect within the first week.
- Duration of effect: 24 hours, daily dosing.
- Dosing pattern: daily injection titrated weekly from 0.6 mg to 3.0 mg.
- Delays are usually explained by food, dose or an unrealistic expectation of the endpoint.
Liraglutide timeline
| Stage | When | What to expect |
|---|---|---|
| First dose | Day 1 | Absorption begins; the pharmacological effect appears within appetite effect within the first week. |
| Early phase | Week 1–2 | Tolerability is established. Mild nausea is most common now. |
| Assessment point | Week 4 | Prescribers judge response and decide whether to hold or titrate. |
| Steady state | Week 8–12 | Full therapeutic benefit for weight management and type 2 diabetes is judged here. |
What slows it down
A heavy or high-fat meal, an under-titrated dose, missed doses and interacting medicines all delay the response to Liraglutide. Storage matters too: product held outside 2–8 °C cold chain until first use can lose potency before it reaches the patient.
When to reassess
If there is no benefit after a full trial at the licensed dose, the standard next steps are dose escalation within range, adherence review, or a switch to Semaglutide.
Liraglutide at a glance
| Attribute | Detail |
|---|---|
| Drug class | GLP-1 receptor agonist |
| Common brand | Saxenda / Victoza |
| Licensed use | weight management and type 2 diabetes |
| Available strengths | 6 mg/mL multi-dose pen |
| Dosage form | prefilled pen |
| Typical onset | appetite effect within the first week |
| Duration / dosing interval | 24 hours, daily dosing |
| Storage | 2–8 °C cold chain until first use |